Abstract
Vascular endothelial growth factor (VEGF) is an important factor mediating tumour angiogenesis. VEGF mRNA is differentially expressed in bladder cancer with high expression in superficial tumours (stage pTaand pT1) contrasting with low expression in muscle invasive tumours (stage ≥ pT2). To investigate mechanisms regulating VEGF expression in bladder cancer, VEGF mRNA and protein were measured in normal bladder (n = 12) and primary bladder cancers (n = 57). VEGF protein levels correlated with mRNA expression in normal bladder (r = 0.68, P = 0.02) and bladder cancer (r = 0.46, P = 0.0007). Whilst VEGF mRNA expression was threefold higher in superficial compared to muscle invasive bladder cancers (P = 0.0001) there was no difference in VEGF protein (P = 0.81). Accordingly, the median protein:mRNA ratios increased more than 15-fold with increasing tumour stage (P< 0.0001) suggesting translational regulation. Expression of the eukaryotic initiation factor-4E (eIF-4E), a factor implicated in the translational regulation of VEGF, was greater in tumours than normal bladder (P< 0.0001) and correlated with VEGF protein:mRNA ratios (n = 43, r = 0.54, P = 0.0004) pointing to its role in the regulation of VEGF. In superficial tumours (n = 37) high expression of eIF-4E was associated with a poor prognosis and reduced stage progression-free survival (P = 0.04, Cox proportional hazards model). The study demonstrates that eIF-4E may be involved in translational regulation of VEGF in bladder cancer and might have a role as a prognostic factor in bladder cancer. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anthony B, Carter P and De Benedetti A (1996) Overexpression of the proto-oncogene/translation factor 4e in breast carcinoma cell lines. Int J Cancer 65: 858–863
Bochner BH, Cote RJ, Groshen S, Esrig D, Freeman JA, Weidner N, Chen S-C, Skinner DG and Nichols PW (1995) Angiogenesis in bladder cancer: relationship between microvessel density and tumour prognosis. J Natl Cancer Inst 87: 1603–1612
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248–254
Chomczynski P and Saachi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
Crew JP, O'Brien TS, Bradburn M, Fuggle S, Bicknell R, Cranston D and Harris AL (1997) Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 57: 5281–5285
Darnbrough C, Legon S, Hunt T and Jackson RJ (1973) Initiation of protein synthesis: evidence for messenger RNA-independent binding of methionyl-transfer RNA to the 40 S ribosomal subunit. J Mol Biol 76: 379–403
De Benedetti A and Rhoads RE (1990) Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 87: 8212–8216
De Benedetti AS, Joshi-Barve S, Rinker-Schaeffer C and Rhoads RE (1991) Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4. Mol Cell Biol 11: 5435–5445
Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN and Harris AL (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74: 762–766
Ferrara N and Davis-Smyth TD (1997) The biology of vascular endothelial growth factor. Endocr Rev 10: 4–25
Jaeger T, Weidner N, Chew K, Moore D, Kerschmann R, Waldmann F and Carroll P (1995) Tumour angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 154: 69–71
Jones R, Branda J, Johnston K, Polmenis M, Gadd M, Rustgi A, Callanan L and Schmidt E (1996) An essential E box in the promotor of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol 16: 4754–4764
Kerekatte V, Smiley K, Hu B, Smith A, Gelder F and De Benedetti A (1995) The proto-oncogene/translation factor eIF-4E: a survey of its expression in breast carcinomas. Int J Cancer 64: 27–31
Kevil C, Carter P, Hu B and De Benedetti A (1995) Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 11: 2339–2348
Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS and Alexander JS (1996) Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumour angiogenesis. Int J Cancer 65: 785–790
Li BD, Liu L, Dawson M and De Benedetti A (1997) Overexpression of eukaryotic initiation factor 4E (eIF-4E) in breast carcinoma. Cancer 79: 2385–2390
Marcus A (1970) Tobacco mosaic virus ribonucleic acid-dependent amino acid incorporation in a wheat embryo system. Analysis of the rate limiting reaction. J Biol Chem 245: 955–961
Nathan CA, Liu L, Li BD, Abreo FW, Nandy I and De Benedetti A (1997) Detection of the proto-oncogene eIF-4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 15: 579–584
O’Brien TS, Cranston D, Fuggle S, Bicknell R and Harris AL (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55: 510–513
O'Brien TS, Cranston D, Fuggle S, Bicknell R and Harris AL (1997) Two mechanisms of basic fibroblast growth factor induced angiogenesis in bladder cancer. Cancer Res 57: 136–140
Rhoads RE (1993) Regulation of eukaryotic protein synthesis by initiation factors. J Biol Chem 268: 3017–3020
Rosenwald IB, Rhoads DB, Callana LD, Isselbacher KJ and Schmidt EV (1993) Increased expression of the eukaryotic translation initiation factor eIF-4E and eIF-2A in response to growth induction by c- myc. Proc Natl Acad Sci 90: 6175–6178
Sacks NPM, Smith K, Norman AP, Greenall M, Lejeune S and Harris AL (1993) Cathepsin D levels in primary breast cancer: relationship with epidermal growth factor receptor, oestrogen receptor and axillary node status. Eur J Cancer 29A: 426–428
Scott PAE, Smith K, Bicknell R and Harris AL (1997) A reliable external control for ribonuclease protection assays. Nucleic Acids Res 25: 1305–1306
Scott PAE, Smith K, Poulsom R, De Benedetti A, Bicknell R and Harris AL (1998) Differential expression of vascular endothelial growth factor mRNA versus protein isoforms expression in human breast cancer and relationship to eIF-4e. Br J Cancer 77: 2120–2128
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Crew, J., Fuggle, S., Bicknell, R. et al. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer 82, 161–166 (2000). https://doi.org/10.1054/bjoc.1999.0894
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.0894
Keywords
This article is cited by
-
Processing body (P-body) and its mediators in cancer
Molecular and Cellular Biochemistry (2022)
-
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma
Investigational New Drugs (2018)
-
Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma
Journal of Cancer Research and Clinical Oncology (2016)
-
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
Oncogene (2015)
-
Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice
Cancer Gene Therapy (2013)
